
GLI names 17 minority business owners for Power to Prosper cohort
By submitting your information you are agreeing to our Privacy Policy and User Agreement .
The latest cohort of GLI's Power to Prosper Accelerator includes a diverse group of entrepreneurs, from plumbers to counselors, all aiming to scale their businesses in unique ways.
Story Highlights GLI's Power to Prosper Business Accelerator selects 17 minority entrepreneurs.
Eight-month program offers free resources to scale Louisville-area businesses.
Previous cohorts created 125 jobs with 58% average growth rate.
A group of 17 minority business owners was recently named to take part in the fifth cohort of the Greater Louisville Inc.'s (GLI) Power to Prosper Business Accelerator, which began on Thursday.
The eight-month program provides founders resources and networks to help scale their businesses within the Louisville metro area.
'Our Power to Prosper Business Accelerator is truly driving inclusive economic development in Greater Louisville. Since its inception, the accelerator has helped more than four dozen businesses grow their revenue, operations, and impact,' said GLI President/CEO Sarah Davasher-Wisdom in a news release. 'Thank you to our investors for continuing to support this program, and we look forward to seeing this cohort grow in the program and in the community.'
The cost per individual in the program is assessed at $15,000 — but it is offered for free thanks to support from Papa Johns International (Nasdaq: PZZA) and Suntory Global Spirits (the parent company of Jim Beam and Maker's Mark).
The accelerator consists of biweekly sessions that cover topics such as financial management, human resources, marketing and sales, contract development and access to capital. Its curriculum is based on Interise's StreetWise MBA model, which uses a peer-learning method.
Interise, which is the main sponsor of the accelerator, is a Boston-based nonprofit organization with a goal of providing support to small businesses that are either located in low- and moderate-income areas — or minority owned, according to Interise's website.
'Every year, it is rewarding to watch these entrepreneurs learn and grow through the curriculum of the Power to Prosper Accelerator,' said GLI's Dana Johnson in the release. Not only will this program help grow 17 small businesses in our region, but the focus on assisting entrepreneurs from historically underrepresented populations is truly breaking down systemic barriers in our community.'
Johnson serves as the vice president of economic inclusion at GLI.
The 17 business owners who were chosen for the cohort are as follows:
LaShay Calvin, owner, Auntie's LLC
Maizie Clarke, owner, Maizie Clarke LLC
Kim Heinzen, co-owner, American Bluegrass Marble
Jackie Jones, owner, Vita Shot Beverage Bar LLC (Amour Farm)
Demoine Lee, owner/master plumber, DrainPros Plumbing
Tiffany Marshall, owner, Pretty Birdie LLC
Robin Miller, owner, NEST Community Marketing
Laquita Moore, owner, Quita's Quisines
Shawnas Moore, owner, Hair Archi-Texture LLC
Curtis Nelson, owner, Bluegrass Counseling Associates
Ashlee Northington, owner, Happy Belly Bistro
Karen Phillips, owner, P31 Cold Storage
Roshunder Rucker, owner, Future Pioneers Learning Center Inc.
Pheniece Semien, owner, Spero Management LLC
Nina Smith, owner, Smith & Associates Counseling
Dana Spencer, owner, Just in Time 4 502 LLC
The accelerator is one component of GLI's Prosper 2030 Strategic Plan. Per the release, accelerator participants take part in a survey one year after graduation to keep record of the results and progress of those business owners that participate.
Based on the results of the first two cohorts alone, 125 jobs have been created or retained with 96% of them hiring from the local community. In addition, 79% of them reported as following the growth program that was developed within the program — with 30% receiving additional financing to grow their businesses. Their average growth rate was 58% (from one year out).
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Cantor Fitzgerald Initiates Coverage on Docebo (DCBO) With an Overweight Rating
Docebo Inc. (NASDAQ:DCBO) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 9, analyst Yi Fu Lee from Cantor Fitzgerald initiated coverage on Docebo Inc. (NASDAQ:DCBO) assigning an Overweight rating with a price target of $35 on the stock. This marks the first rating on the stock from Cantor Fitzgerald indicating firms' confidence in the company's potential and the overall industry condition. Docebo Inc. (NASDAQ:DCBO) is a leading learning platform that uses AI and innovation as its backbone. The company announced results for its fiscal first quarter of 2025 on March 9. The subscription revenue grew 13% year-over-year to $54.2 million, representing 95% of the total revenue. Whereas the total revenue also grew 11% year-over-year to $57.3 million. Notably, net income came in at $1.5 million. Both the revenue and EPS exceed market expectations, with revenue beating the consensus by $0.2 million and EPS topped by $0.05. A professional instructor delivering a customer education workshop. Management is anticipating second-quarter revenue between $59.0 million and $59.2 million. It expects subscription revenue to grow about 1.5% higher than overall company revenue. Docebo Inc. (NASDAQ:DCBO) provides an AI-powered learning platform that helps organizations create, manage, and deliver personalized training programs at scale. The company's platform enables organizations to deliver advanced learning experiences for its employees to drive measurable growth. While we acknowledge the potential of DCBO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
17 minutes ago
- Yahoo
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating
Disc Medicine, Inc. (NASDAQ:IRON) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 11, analysts from Raymond James resumed coverage of Disc Medicine, Inc. (NASDAQ:IRON) with a strong Buy rating and a price target of $89. The resumed coverage comes as the company released its research note on Biotech names. The firm highlighted a favorable risk/reward profile in the biotech sector. It noted that while companies with a high probability of success for lead assets inspire higher conviction, investments in less de-risked assets like Disc Medicine, Inc. (NASDAQ:IRON) could yield the most outsized returns. The firm sees more than $1 billion potential for the company's drug bitopertin, with an expected market penetration of about 30%-35%, owing to its disease-modifying agent capabilities X-linked protoporphyria. A scientist in a laboratory setting examining a sample of blood with a microscope. Disc Medicine, Inc. (NASDAQ:IRON) is a clinical-stage biopharmaceutical company focused on discovering therapies for serious hematologic diseases. Its pipeline includes drug candidates like bitopertin for erythropoietic porphyrias and Diamond-Blackfan Anemia, DISC-0974 for anemia related to myelofibrosis and chronic kidney disease, and DISC-3405 for polycythemia vera and other blood disorders. While we acknowledge the potential of IRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
20 minutes ago
- Yahoo
RBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patient Survey
Gilead Sciences Inc. (NASDAQ:GILD) is one of the 11 most profitable NASDAQ stocks to buy now. On June 11, RBC Capital increased its price target for Gilead Sciences to $95 from $92, while maintaining a Sector Perform rating. This adjustment is based on insights from a 2022 patient survey, which assessed perceptions of lenacapavir among high-risk individuals on and off PrEP (pre-exposure prophylaxis), especially after phase 3 data release and in anticipation of its potential market launch. The firm's analysis suggests that high clinician engagement, lower-than-expected adherence to oral PrEP medications, and the potential for current PrEP users to switch to lenacapavir could all facilitate growth for Gilead Sciences, even with some cannibalization of its existing product called Descovy. A physician and a patient having a discussion in a hospital about biopharmaceutical medicines. In Q1 2025, Gilead Sciences reported total revenue of $6.67 billion, which was flat year-on-year and missed Street's estimates by 2.1%. Despite the revenue miss, Gilead reconfirmed its full-year revenue guidance at the midpoint of $28.4 billion, which is 1.1% below analysts' estimates. These results were driven by growth in the company's core HIV and liver disease segments, particularly from strong demand for Biktarvy and the ongoing launch of Libdelzi. Gilead Sciences Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need in the US, Europe, and internationally. While we acknowledge the potential of GILD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.